Last reviewed · How we verify
Balance, Fresenius Medical Care, Germany — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Balance, Fresenius Medical Care, Germany (Balance, Fresenius Medical Care, Germany) — Kyungpook National University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Balance, Fresenius Medical Care, Germany TARGET | Balance, Fresenius Medical Care, Germany | Kyungpook National University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Balance, Fresenius Medical Care, Germany CI watch — RSS
- Balance, Fresenius Medical Care, Germany CI watch — Atom
- Balance, Fresenius Medical Care, Germany CI watch — JSON
- Balance, Fresenius Medical Care, Germany alone — RSS
Cite this brief
Drug Landscape (2026). Balance, Fresenius Medical Care, Germany — Competitive Intelligence Brief. https://druglandscape.com/ci/balance-fresenius-medical-care-germany. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab